Latvia vs Lithuania: Access to anti-retroviral drugs, male
Latvia
51.0%
in 2024
Lithuania
50.0%
in 2024
Latvia rank
116th
Lithuania rank
117th
Access to anti-retroviral drugs, male over time
- Latvia
- Lithuania
How they compare
Latvia currently reports 51.0% against 50.0% in Lithuania, a difference of 1.0%.
The two have swapped places 6 times across 25 shared years of data; in 2000 it was Latvia ahead.
Latvia ranks 116th and Lithuania ranks 117th of 141 countries.
Across the 3 decades both report, Latvia averaged higher in 2 and Lithuania in 1.
Head to head by decade
| Decade | Latvia | Lithuania | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 3.3% | 3.5% | 0.2% | Lithuania |
| 2010s | 22.3% | 21.8% | 0.5% | Latvia |
| 2020s | 49.0% | 43.4% | 5.6% | Latvia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Latvia or Lithuania?
- Latvia, at 51.0% against 50.0% in Lithuania as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Latvia and Lithuania?
- 1.0%, with Latvia ahead.
- How many years of comparable data are there for Latvia and Lithuania?
- 25 years are reported by both, from 2000 to 2024.
- How do Latvia and Lithuania rank globally for access to anti-retroviral drugs, male?
- Latvia ranks 116th and Lithuania ranks 117th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.